Nootropic Pouches Launch · Slot 01
Hey Michael,
This is something you need to hear directly from me.
In 2010, a government scientist in Baltimore pooled 41 placebo-controlled studies to answer a question that matters to 48.6 million American adults (CDC): does nicotine make you sharper? It does. A little. (National Institute on Drug Abuse)
A year earlier at Yale, 30 daily smokers went 17 hours without one. Reaction time slowed. Errors went up. Answers came out uneven.
If your last one was at nine last night, two this afternoon is hour seventeen.
The focus he buys is the focus the last one took.
Who gets paid, and who pays
• 3.2 billion doses of smoke-free nicotine shipped in the US in three months (Philip Morris International, SEC filing, Oct 21)
• $21.7 billion to the states this year from tobacco. 3.4% spent on helping anyone stop. (Tobacco-Free Kids)
• $185 billion a year in lost productivity from smoking (CDC)
Dependence, sold as productivity. Every link in that chain gets paid when he reaches for it again.
So I went looking at what sharpness looks like with nothing hooked to it.
SEE WHAT THEY FOUND →Over the next few emails I will show you what we found. Keep an eye on your inbox.
To your health,
Antonio
CEO, Black Forest Supplements
Merge tags render live on send; shown here with a sample first name. Subject as built: Worth reading, {{ person.first_name|default:'' }}!
Working title: “Dependence Nation”
Baltimore, 2010. Forty-one studies and one question: does nicotine actually make you sharper? The answer is the most profitable trade in America, and almost nobody selling it wants the second half read out loud. Full text on the blog page. 2,408 words, 9 H3, 5 images, in-article SMS opt-in tagged sms-ask · dependence-nation. Modelled on Remedy, Dr. Sumi and Heart Attack Nation. Product-free and format-free.
| Act | What it does, and what binds it |
|---|---|
| 1 · Baltimore, 2010 (cold open) | A named government scientist, a place, a year, one question: does nicotine make you sharper? Forty-one studies say yes, modestly, “not confounded by withdrawal relief.” Nicotine works. Remedy/Sumi spine: named person, place, date, one finding. Source H6 (Heishman 2010, NIDA). |
| 2 · New Haven, 2009 | Yale, thirty smokers, 0/5/17 hours: reaction time slowed, errors rose, answers uneven. Hour seventeen = two this afternoon. Vermont's 120-study review and the CDC list concentration as withdrawal. The second half of the finding. Sources H14, H15, H7. “Part of” kept: no single study measures gain and loss in one person. |
| 3 · The man at two in the afternoon | The day told as a story: fine morning, the swim at two, the dose, the fog lifting, “this helps me focus.” Pull line: Dependence, sold as productivity. Antonio rule 3: the mechanism felt, not listed. A composite, no invented study detail. |
| 4 · The cigarette was dying | PMI's Oct 21 SEC filing (3.2B, price premium, Olczak's “combustible”). FDA 2025: fewer harmful constituents, “not safe.” Ottawa 2025: 91.73%. The ledger: seven lines, each with its institution, including $185B lost productivity. Heart Attack Nation's stat block. Sources H1, H13, H4, H5, H9, H8. |
| 5 · The $21.7 billion reason | Six paid links: the daily customer, the states' cut, the marketing, the careful regulator, the court's 2006 finding and corrective statement on nicotine delivery, end of the line. Reader exonerated. In-article SMS opt-in. Sumi's six-step loop. Sources H1, H8, H4, H10. Court in its own words; never “deceived.” “Same industry,” never “same company.” |
| 6 · The next customer is in middle school | FDA's own release: 1.8% of middle and high school students. The same trade, earlier. Grandfather's warning label vs a habit that fits in a pocket. Ladder to the biggest stake (manifesto playbook #8). Source H4. |
| 7 · Who gets paid when you can't focus | Every link paid (PMI, the states, $8.6B marketing, $240B health care spending on smoking in 2018); the man pays for all of it. The mission: help Americans live better and break free from a system that profits from their sickness. No stop-using push. “The hook is a business decision.” Withhold, then JOIN THE LIST (email + optional phone). Remedy's withhold plus the brand purpose. Sources H6, H8, H9. Product invisible; no active named. |
| 8 · His father's habit had a smell. His doesn't. | Gut-punch close, reply ask, signature, education disclaimer. Sumi/Remedy closing H3 pattern. |
Subject (approved): “Worth reading, {first_name}!”
Opens the arc, product-free and format-free, with the nicotine economy: the cigarette companies moved the smoker into ZYN, the states are paid for it, and the focus nicotine sells is partly its own withdrawal. Every figure in the brief is a read document. The copy names Philip Morris and nicotine; canon bans the competitor brand in copy, so the filing is quoted with the brand bracketed out, and it may not say pouch, product, dose or price.Product-free, and format-free. Must not say the product, its name, any SKU, any dose, any price, paraxanthine, citicoline, theacrine, or the words pouch / pouches; the format and the category word are reserved for the Oct 29 reveal (Juan, Oct 20).
The cigarette companies did not lose the smoker; they moved him. Philip Morris shipped 3.2 billion ZYN in the three months to September and is changing the can size to optimize the price premium (SEC-filed release, Oct 21). The states will collect $21.7B this fiscal year from tobacco and spend 3.4% of it on quitting; the industry outspends that nearly 12 to 1 (Tobacco-Free Kids FY2026). In 2006 a federal court found the cigarette makers had for decades conspired to deny the health effects of smoking and ordered corrective statements (D.C. Cir. 2017, the court's words). Nicotine sharpens attention in 41 placebo-controlled studies (Heishman 2010), and 'having a hard time concentrating' is on the CDC's list of withdrawal symptoms. Smoking cost $600B in 2018 (CDC).
The vocabulary rule: the copy names nicotine and Philip Morris; it may not say pouch, and canon bans the competitor brand in copy (draft v1 quotes the filing with the brand bracketed out). Naming the brand would also tell an informed reader the enemy is a pouch. Juan can lift the ban; until then the story is told without it. Altria is not named: its on! release has only been read as a search summary. No cessation framing anywhere: this send describes a trade the reader is making, it never offers to end it. Never 'deceived': the court struck that word from the preambles; say what it found.
Neutonic, 124 days live: “Caffeine gum tastes like medicine. Coffee stains your teeth and needs a machine.” Ultra, 33 days: “You're not under-caffeinated.” The category sells the format. We open the trade behind it.
Imagery for a product-free send: the shelf, the can, the label with the number missing. Competitor creative for contrast in the gallery, clean-energy, live and dose on the label. House form: the unit chart (dark ground, red squares, one number, a source line) that carried the Oct 20 send.